Pediatric bronchiolitis mechanism found
A new study in Pediatric Research identifies immune-checkpoint dysregulation as a driver of bronchiolitis severity in infants and young children reported. That biological insight helps explain why some infants deteriorate quickly and supports vigilance for early hypoxia and respiratory fatigue in the field.
The article "Pediatric bronchiolitis disease severity is associated with immune checkpoint dysregulation" was published in Pediatric Research (March 2026; DOI 10.1038/s41390-026-04853-4) and lists Mehmet Akif Dündar as first author with Benhur Şirvan Çetin as corresponding author. nature.com Researchers recruited a prospective cohort of 151 children aged 1 month to 2 years and stratified participants into control, mild, moderate, and severe bronchiolitis groups for analysis. nature.com Flow-cytometry analysis showed total CD4+ T cell counts fell as clinical severity rose, while regulatory T cell (CD4+ FOXP3+) frequencies were higher in mild disease but reduced in moderate and severe cases. nature.com Checkpoint receptors CTLA‑4 and TIM‑3 showed increased surface expression on both Treg and non‑Treg CD4+ T cells in the moderate and severe groups, implicating specific inhibitory pathways in worse clinical phenotypes. nature.com Plasma assays found soluble PD‑1, TIM‑3, LAG‑3, TGF‑β1, and 4‑1BB were significantly elevated in severe bronchiolitis, with measurements performed by ELISA alongside the cellular flow‑cytometry work. nature.com The authors concluded that an immunosuppressive checkpoint‑skewed profile could serve as a biomarker set and potential therapeutic target for risk stratification, a finding that aligns with a separate proteomic immunophenotyping study reporting distinct immune-cell and cytokine signatures in hospitalized children with severe bronchiolitis. nature.com
